Secondary |
Chronic Obstructive Pulmonary Disease |
10.9% |
Cardiac Failure |
8.7% |
Infantile Spasms |
8.7% |
Pain |
8.7% |
Diabetes Mellitus Insulin-dependent |
6.5% |
Drug Use For Unknown Indication |
6.5% |
Thrombophilia |
6.5% |
Anaemia |
4.3% |
Bronchitis |
4.3% |
Dyslipidaemia |
4.3% |
Nausea |
4.3% |
Prophylaxis |
4.3% |
Sleep Disorder |
4.3% |
Thrombosis Prophylaxis |
4.3% |
Bronchopulmonary Dysplasia |
2.2% |
Dyspepsia |
2.2% |
Gastritis Prophylaxis |
2.2% |
Hypokalaemia |
2.2% |
Hypopituitarism |
2.2% |
Hypothyroidism |
2.2% |
|
Myalgia |
12.5% |
Neonatal Respiratory Distress Syndrome |
12.5% |
Oligohydramnios |
12.5% |
Rhabdomyolysis |
12.5% |
Stevens-johnson Syndrome |
12.5% |
Suicide Attempt |
12.5% |
Systolic Hypertension |
12.5% |
Vomiting |
12.5% |
|
Concomitant |
Product Used For Unknown Indication |
18.7% |
Hypertension |
12.7% |
Breast Cancer |
11.7% |
Drug Use For Unknown Indication |
8.5% |
Rheumatoid Arthritis |
6.7% |
Pain |
6.1% |
Prophylaxis Against Gastrointestinal Ulcer |
3.1% |
Prophylactic Chemotherapy |
3.0% |
Prophylaxis |
3.0% |
Urinary Tract Infection |
3.0% |
Nausea |
2.8% |
Anaemia |
2.7% |
Iron Deficiency Anaemia |
2.7% |
Type 2 Diabetes Mellitus |
2.6% |
Atrial Fibrillation |
2.4% |
Restless Legs Syndrome |
2.4% |
Prostate Cancer |
2.3% |
Vomiting |
2.1% |
Bone Pain |
1.7% |
Crohn's Disease |
1.7% |
|
Prothrombin Time Prolonged |
8.4% |
Vomiting |
7.4% |
Clostridium Difficile Colitis |
6.3% |
Drug Effect Decreased |
6.3% |
Drug Exposure During Pregnancy |
5.3% |
Pulmonary Embolism |
5.3% |
Pyrexia |
5.3% |
Skin Necrosis |
5.3% |
Suicide Attempt |
5.3% |
Ureteral Stent Removal |
5.3% |
Drug Interaction |
4.2% |
Gastric Haemorrhage |
4.2% |
Neonatal Respiratory Distress Syndrome |
4.2% |
Thrombocytopenia |
4.2% |
Troponin Increased |
4.2% |
Tuberculosis |
4.2% |
Urosepsis |
4.2% |
Vitreous Haemorrhage |
4.2% |
Adrenal Neoplasm |
3.2% |
Electrocardiogram Qt Prolonged |
3.2% |
|
Interacting |
Iron Deficiency |
50.0% |
Sinusitis |
50.0% |
|
Loss Of Consciousness |
100.0% |
|